Skip to content

Art therapy to regulate hypertension - a quantitative, controlled study

Art therapy to regulate hypertension - a quantitative, controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013301
Enrollment
60
Registered
2018-03-12
Start date
2018-03-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I10

Interventions

Group 1: Arm1 - Admission: Questionnaire of inner state (HSI), blood pressure, mobile overnight ECG Intervention: Manualised art therapy over 8 sessions, once a week: - First session: Introduction in
blood pressure measurements, overnight ECG, questionnaire as described above).

Sponsors

Institut für Kunsttherapie und Therapiewissenschaft
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adults capable of taking decisions with diagnosed arterial hypertonia, stable blood pressure medication, longterm known medical history and 24h blood pressure mesurement not older than two years.

Exclusion criteria

Exclusion criteria: - Cushing’s syndrome, Conn’s syndrome, renal artery stenosis - diseases affecting the cardiovascular regulation: thyroid dysfunction, coronary heart diseases, diabetes mellitus - Obesity (body mass index >30)

Design outcomes

Primary

MeasureTime frame
The primary outcome is a decreased blood pressure after the art therapy intervention (RRafter vs. RRbefore). The immediate effects (after therapy vs. before therapy) as well as the medium term improvement of blood pressure will be evaluated (changes between each art therapy session). The long term changes of the inner state will be determined by evaluating the questionnaires (HSI, Heidelberger State Inventoy, Koch, Morlinghaus & Fuchs 2007) at the beginning, in the end of the therapy phase and during the follow up.

Secondary

MeasureTime frame
The secondary outcome will be the evaluation of the standard parameters of heart rate variability during three 5-minute-periods (respectively the central 5 minutes before, during and after the art therapy) according to the HRV standards (Task Force of the European Society of Cardiology and The North American Society of Pacing and Electrophysiology 1996): - The mean RR-interval in milliseconds - The standard deviation of the normal-to-normal heartbeats (SDNN) in milliseconds - The square root of the mean squared NN-differences (RMSSD) in milliseconds - The high frequency component (HF) of spectral analysis (0.15 to 0.4 Hz corresponding 9 to 24 oscillations per minute) - Low frequency component (LF) of the spectral analysis (0.04 to 0.15 Hz corresponding to 2.4 to 9 oscillations per minute) The mentioned HRV parameters will be determined for all subsequent 5-minute intervals during nighttime sleep and subsequently averaged. The ability of recovery can be assessed with this method. The decline of the LF-component or the increase of the HF-component of HRV should be considered as an improvement of the cardiac autonomic regulation. The mentioned changes may be interpreted as a reduction of stress (assessed by a decrease of the LF component). The change of these two components should go along with the alteration of SDNN and RMSSD. Moreover, the physiological sleep quality can be determined from the cardiopulmonary coupling from the overnight ECG (Thomas et al. 2005). Therefore the classification of stable and instable sleep phases by means of the detecion of the high frequency components (stable sleep) and the low frequency components (instable sleep) of cardiopulmonary coupling will be used. An increased physiologic sleep quality and therefore a better ability of recovery of the organism should lead to less phases of instable sleep and more stable sleep phases.

Countries

Germany

Contacts

Public ContactCorinne Roy

Institut für künstlerische therapien und Therapiewissenschaft

corinne.roy@alanus.edu0049 2222 9321 1804

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026